ASCO 2022 Conference Coverage
Playback speed
10 seconds
Lecture Summary - ASCO 2022 Adjuvant Abemaciclib for High-risk Early Breast Cancer: Factors Increasing the Rate of Treatment Discontinuations in monarchE
By
ASCO 2022 Conference Coverage
FEATURING
Sara Tolaney
By
ASCO 2022 Conference Coverage
FEATURING
Sara Tolaney
53 views
July 26, 2022
Comments 0
Login to view comments.
Click here to Login
Breast